PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRT.
Angela Pathmanathan, Suneil Jain, John Staffurth, Stephanie Brown, Stephanie Burnett, Fay H Cafferty, Ananya Choudhury, Monisha Dewan, Peter Hoskin, Ken McBride, Conor K McGarry, Elizabeth Miles, Julia Murray, Vedang Murthy, Olivia Naismith, Yee Pei Song, Isabel Syndikus, Alison Tree, Tim Ward, Emma Hall, Nicholas van As
Clin Transl Radiat Oncol 58 101126
摘要
摘要
PACE-NODES is a phase III randomised controlled trial for patients with high risk localised prostate cancer, planned for radical radiotherapy with at least 12 months of androgen deprivation therapy, and suitable for stereotactic body radiotherapy (SBRT). Patients are randomised to receive either prostate SBRT (control) or prostate and pelvic nodal SBRT. In both arms, treatment is given in 5 fractions delivered on alternate days over 2 weeks. The aim of the trial is to determine whether prostate and pelvic nodal SBRT can improve outcomes for this patient group compared to prostate SBRT. Clinical trial registration: PACE NODES is registered on ClinicalTrials.gov (NCT05613023).
KM 提取结果
0 个 Figure · 0 个 KM 面板